Rate of SVR increases with higher CD4% at baseline: APRICOT
Opravil et al. J Acquir Immuno Defic Syndr 2008;47:36–49
SVR rate (% patients)
Baseline CD4% quartile
33
16
62
36
29
47
41
34
73
47
27
69
0
10
20
30
40
50
60
70
80
90
100
All patients (n=242)
HCV genotype 1
(n=150)
HCV genotypes 2-3
(n=78)
Min – Q1
Q1 – Med
Med – Q3
Q3 – Max